Should Bristol Myers Stock Be in Your Portfolio Pre-Q4 Earnings?

Biotech giant Bristol-Myers Squibb Company (BMY) is scheduled to report its fourth-quarter and full-year 2024 results on Feb. 6, before market open.The Zacks Consensus Estimate for sales and earnings for the fourth quarter is pegged at $11.56 billion and$1.46 per share, respectively.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Earnings estimate for 2024 has increased to 92 cents from 91 cents per share over the past 60 days. It’s worth noting that the annual earnings estimate has ...